RxDoctor Payments Data

Fabio Ricci Gorbea

Internal Medicine · San Juan, PRNPI 1184810962

Payments from drug & device makers

$3,966in general payments, 2019–2025

Across 190 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$885
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$764
  • Boehringer Ingelheim$589
  • Johnson & Johnson$358
  • E.r. Squibb & Sons, L.L.C.$351
  • PBG Puerto Rico LLC$309
  • plus $710 from 8 others

What the payments were for

  • Food & beverage$3,87198%
  • Education$952%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca42$885
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)53$764
Boehringer Ingelheim25$589
Johnson & Johnson16$358
E.r. Squibb & Sons, L.L.C.16$351
PBG Puerto Rico LLC14$309
Boston Scientific6$296
Abbott6$114
Merck5$103
Medtronic1$72
Novartis2$46
Amgen2$40
Scpharmaceuticals Inc.1$22
Johnson And Johnson International1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,966 in reported general payments places this provider in the 90th percentile of 1,043 internal medicine providers in Puerto Rico.

See all internal medicine providers in Puerto Rico

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan402$488,687
EliquisApixaban357$429,539
XareltoRivaroxaban365$409,158
FarxigaDapagliflozin Propanediol345$356,014
JardianceEmpagliflozin101$127,371
BrilintaTicagrelor78$68,717
JanuviaSitagliptin Phosphate39$43,689
SynthroidLevothyroxine Sodium316$39,784
Repatha SureclickEvolocumab51$31,192
Metoprolol Succinate1,205$30,981
Atorvastatin Calcium1,079$16,369
Candesartan Cilexetil79$10,948
Candesartan-HydrochlorothiazidCandesartan/Hydrochlorothiazid51$10,699
Losartan Potassium642$9,756
Irbesartan244$9,628

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$46$488,687402 claims
AstraZenecaFarxiga, Brilinta$885$424,731423 claims
Johnson & JohnsonXarelto$358$409,158365 claims
Boehringer IngelheimJardiance$589$127,371101 claims
MerckJanuvia$103$43,68939 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,043 internal medicine providers in Puerto Rico.

Other internal medicine in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →